Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Volatility Of Total Stock Market Retirement explains the inherent swings of broad equity exposure and how to keep a retirement plan on track.
28,166 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Axon Enterprise stock popped as investors weighed the company’s expanding product lineup, software growth, and a grow...
Dell Technologies grabbed headlines as its AI-focused strategy started to show momentum. This piece breaks down why d...
Shimmick's Q1 2026 results offer a window into infrastructure demand and cost pressures. This article breaks down the...
In mid-2026, the Amplify CWP Enhanced Dividend Income ETF climbs past $5.25 billion in assets as its monthly distribu...
Today's market action centers on semiconductor chatter, a solid Micron after-hours surge, and a mixed read across maj...
The US is accelerating domestic rare-earth initiatives, and investment banks keep raising targets on MP Materials. Th...
Turn your Friday into a productivity booster with ten thoughtful friday reads. Each piece blends big-picture finance ...
Private equity is moving from wall street legends to the everyday investor. Here’s how cathie wood's private equity i...
Investors weighing Dow and LYB face a crossroads in 2026. This guide breaks down business models, catalysts, risks, a...
NVIDIA stock hovers in the mid-$170s, as traders debate whether the company can reach $500 per share by 2030 through ...
Piper Sandler moved to downgrade its Fastly target after Q1 FY2026 showed slowing core delivery volumes. The stock dr...